Cambridge, MA – The Workers Compensation Research Institute (WCRI) recently released a new report that gathers in one place the numerous state regulations affecting drugs prescribed to workers with injuries in all 50 states and the District of Columbia.
“Across the country, states have implemented an array of different regulatory strategies, overseen by different agencies, to address prescribing of medicine,” said Ramona Tanabe, WCRI’s executive vice president and counsel. “This report provides policymakers and system stakeholders with a basic understanding of the different strategies adopted by states, with references to the regulations for those seeking more detail.”
The report, Workers’ Compensation Prescription Drug Regulations: A National Inventory, 2020, also provides information on some of the most prominent prescription drug issues stakeholders are concerned about today, such as the following:
- Rules for Limiting and Monitoring Opioid Prescriptions
- Medical Marijuana Regulations
- Workers’ Compensation Drug Formularies
- Prescription Drug Monitoring Programs
- Price Regulations for Pharmacy- and Physician-Dispensed Drugs
- Drug Testing Regulations
The tables in this report were compiled from completed surveys of two agencies for each of the 50 states and the District of Columbia as of January 1, 2020. The report was authored by Karen Rothkin.
For more information or to purchase a copy: Workers’ Compensation Prescription Drug Regulations: A National Inventory, 2020